Evotec SE announced the appointment of Dr. Ingrid Mller as Chief Operating Officer (COO), effective May 1, 2026. Dr. Mller will be joining Evotec's Management Board. She brings to Evotec more than 20 years of international leadership experience in the life sciences industry across operations, strategy, supply, procurement and R&D integration.
In her role as COO, Dr. Mller will oversee Evotec's global operations and implementation of the Horizon initiative, with a focus on quality, productivity, scalability, delivery, cost and the continued advancement of technological improvements across the business. Most recently, Dr. Mller served as Vice President Portfolio Strategy & Execution at CureVac. Prior to that, she held senior international leadership roles at Sanofi and Fresenius Kabi, where she was instrumental in strengthening supply resilience, implementing make-or-buy strategies, supporting growth and margin expansion, and delivering annual savings and cash-flow improvements.
